{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:37:39Z","timestamp":1787236659276,"version":"build-2736575974"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T00:00:00Z","timestamp":1100736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Bone metastases represents a common cause of morbidity in patients suffering many types of cancer: breast, lung, kidney, prostate, and multiple myeloma. Osteolytic metastases often cause severe pain, pathologic fractures, hypercalcemia, spinal cord compression, and other nervecompression syndromes. Osteoclasts (OCs), cells deriving from granulocitic\u2010macrophagic lineage, are responsible for osteolysis, which may be reduced by inhibiting both OCs formation and activity. By studying bone osteolytic metastases mechanism in solid tumors, we report here our findings that cancer patients with bone involvement display an increase in osteoclasts precursors, compared with both healthy controls and cancer patients without bone metastases. Peripheral blood mononuclear cells (PBMCs) from patients with osteolytic lesions show osteoclastogenesis without adding M\u2010CSF, RANKL, or TNF\u2010\u03b1. However, these factors are necessary to generate OCs from healthy donors, non\u2010osteolytic patient PBMCs and T\u2010cell depleted PBMCs. OCs derived from cancer patients show more resorption pits than OCs from healthy donors and express genes involved in osteoclastogenesis. Our data show that a spontaneous osteoclastogenesis occurs in patients affected by osteolytic lesions and may be supported by factors released by T lymphocytes. These factors could give a priming to osteoclast precursors and promote osteoclastogenesis. In fact, T\u2010cell depleted PBMCs do not differentiate into OCs without adding M\u2010CSF and RANKL. Moreover, we do not obtain a higher number of OCs by increasing RANKL doses in cultures, and OCs and T lymphocytes mRNA level are detected for TNF\u2010\u03b1 but not for RANKL. The addition of OPG to PBMCs cultures do not modify spontaneous osteoclastogenesis. A neutralizing anti\u2010TNF\u2010\u03b1 antibody in unstimulated PBMC cultures of osteolytic cancer patients induces an inhibition of osteoclastogenesis. These data suggest that TNF\u2010\u03b1 may be responsible for osteoclastogenesis in these tumors.<\/jats:p>","DOI":"10.1096\/fj.04-1823fje","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T20:24:44Z","timestamp":1100809484000},"page":"1-24","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement"],"prefix":"10.1096","volume":"19","author":[{"given":"Ilaria","family":"Roato","sequence":"first","affiliation":[{"name":"CeRMS (Center for Experimental Research and Medical Studies) University and A.S.O. San Giovanni Battista  Turin Italy"},{"name":"Department of Medical Oncology University and A.S.O. San Giovanni Battista  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grano","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy and Histology University of Bari  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Brunetti","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy and Histology University of Bari  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Colucci","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy and Histology University of Bari  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mussa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology University and A.S.O. San Giovanni Battista  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Bertetto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology University and A.S.O. San Giovanni Battista  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Ferracini","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics A.S.O. San Giovanni Battista  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,11,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316069"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.160.1.403","article-title":"IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis","volume":"160","author":"Assuma R.","year":"1998","journal-title":"J. Immunol."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.34071"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1504"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01491.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11419"},{"key":"e_1_2_6_10_1","first-page":"1392","article-title":"Osteoclast precursors circulate in the peripheral blood of patients with aggressive multiple myeloma","volume":"9","author":"Gregoretti M. G.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.133.5.7691583"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3597"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064753"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.12.1741"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65266-2"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5134"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.2.275"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.7.4858"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(02)00106-7"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.11.013"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.041"},{"key":"e_1_2_6_25_1","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf A. M.","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc820"},{"key":"e_1_2_6_27_1","first-page":"5663","article-title":"Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens","volume":"45","author":"Horton M. A.","year":"1985","journal-title":"Cancer Res."},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.83B4.0830471"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/endo.139.10.6331","article-title":"A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro","volume":"139","author":"Quinn J. M.","year":"1998","journal-title":"Endocrinology"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/cs0990133","article-title":"Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL)","volume":"99","author":"Nicholson G. C.","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1190"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","unstructured":"Colucci S. Brunetti G. Rizzi R. Zonno A. Mori G. Colaianni G. Del Prete D. Faccio R. Liso A. Capalbo S. et al. (2004)T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/Trail interaction.Blood","DOI":"10.1182\/blood-2004-02-0474"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.3.0367"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V77.12.2688.2688","article-title":"Role of bone marrow stromal cells in the growth of human multiple myeloma","volume":"77","author":"Caligaris-Cappio F.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.19.13613"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4","author":"Takayanagi H.","year":"2002","journal-title":"Arthritis Res."},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.634"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1121"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(00)00211-9"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.201"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.10.5211"},{"key":"e_1_2_6_42_1","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody","volume":"59","author":"Onizuka S.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_6_43_1","first-page":"4766","article-title":"Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer","volume":"61","author":"Woo E. Y.","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4272"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2756"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1823fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.04-1823fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1823fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:29:17Z","timestamp":1761679757000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-1823fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,18]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1096\/fj.04-1823fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.04-1823fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,18]]},"assertion":[{"value":"2004-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}